Mesenchymale Stammzellen zur Geweberegeneration und zur Immunsuppression

Schlüsselwörter

Mesenchymale Stammzellen - Abstoßungsreaktion

Key words

mesenchymal stem cells - Graft-versus-Host-Disease

Literatur

• 1 Aggarwal S, Pittenger M F. Human mesenchymal stem cells modulate allogeneic immune cell responses.  Blood. 2005;  105 1815-1822
• 2 Devine S M, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.  Blood. 2003;  101 2999-3001
• 3 Djouad F, Fritz V, Apparailly F. et al . Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.  Arthritis Rheum. 2005;  52 1595-1603
• 4 Djouad F, Plence P, Bony C. et al . Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.  Blood. 2003;  102 3837-3844
• 5 Fouillard L, Bensidhoum M, Bories D. et al . Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma.  Leukemia. 2003;  17 474-476
• 6 Frassoni F, Labopin M, Bacigalupo A. Expanded mesenchymal stem cells (MSC), co-infused with HLA-identical hematopoietic stem cell transplants, reduce acute and chronic graft-versus-host disease: a matched pair analysis (abstract 75).  Bone Marrow Transplant. 2002;  (suppl 2) 29 S2
• 7 Horwitz E M, Gordon P L, Koo W K. et al . Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.  Proc Natl Acad Sci U S A. 2002;  99 8932-8937
• 8 Ishida T, Inaba M, Hisha H. et al . Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation.   J Immunol. 1994;  152 3119-3127
• 9 Jorgensen C, Djouad F, Fritz V, Apparailly F, Plence P, Noel D. Mesenchymal stem cells and rheumatoid arthritis.  Joint Bone Spine. 2003;  70 483-485
• 10 Koc O N, Day J, Nieder M. et al . Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).  Bone Marrow Transplant. 2002;  30 215-222
• 11 Koc O N, Gerson S L, Cooper B W. et al . Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.  J Clin Oncol. 2000;  18 307-316
• 12 Le Blanc K, Gotherstrom C, Ringden O. et al . Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.  Transplantation. 2005;  79 1607-1614
• 13 Le Blanc K, Rasmusson I, Sundberg B. et al . Treatment of severe acute graft-versus-host disease with third partly haploidentical mesenchymal stem cells.  Lancet. 2004;  363 1439-1441
• 14 Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.  Biol Blood Marrow Transplant. 2005;  11 321-334
• 15 Wagner W, Wein F, Seckinger A. et al . Comparative characterization of mesenchymal stem cells from human bone marrow, adipose tissue and umbilical cord blood.  Exp Hematol. 2005;  33 1402-1416
• 16 Lazarus H M. et al . Ex vivo expansion and subsequent infusion of human bone-marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.  Bone Marrow Transplantation. 1995;  16 557